These compounds may interact with:

Dual specificity tyrosine-phosphorylation-regulated kinase 1A

Potentially involved in: autism spectrum disorder; intellectual disability; metabolic syndrome x; carcinoma; acquired immunodeficiency syndrome; down syndrome; microcephaly; alzheimer's disease; hyperhomocysteinemia; autistic disorder; bunion; febrile convulsions; enophthalmos; hallux valgus; mental retardation; cerebral atrophy; sunken eyes; low intelligence; small head; mental deficiency

Disease data sourced from Pharos.